What we look for
- Principal investigators who are excited to treat novel targets with first-in-human radiotheranostics, and whose centers can image and treat within the same program.
- Radionuclide producers who can supply ¹⁷⁷Lu, ⁶⁸Ga generators, and alpha emitters on the day they are needed, not the week.
- GMP manufacturing partners in Europe, North America, and Asia-Pacific who would rather solve a labeling problem with us than hand it back.
- Companies with targets, binders, or chelation technology to license in or out.
- Investors with experience of the field and patience for its clock.